Combinatorial epigenetic therapy in diffuse large B cell lymphoma pre-clinical models and patients Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Antineoplastic Combined Chemotherapy Protocols
  • Histone Deacetylase Inhibitors
  • Lymphoma, Large B-Cell, Diffuse

abstract

  • Our data supports the strategy of epigenetic priming by employing DNMTI in RR-DLBCL patients in order to overcome resistance and improve their outcomes.

publication date

  • July 22, 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4957280

Digital Object Identifier (DOI)

  • 10.1186/s13148-016-0245-y

PubMed ID

  • 27453763

Additional Document Info

start page

  • 79

volume

  • 8

number

  • 1